Conversion of human bone marrow-derived mesenchymal stem cells into tendon progenitor cells by ectopic expression of scleraxis.

PubWeight™: 1.91‹?› | Rank: Top 3%

🔗 View Article (PMC 3315756)

Published in Stem Cells Dev on October 11, 2011

Authors

Paolo Alberton1, Cvetan Popov, Markus Prägert, Julia Kohler, Chisa Shukunami, Matthias Schieker, Denitsa Docheva

Author Affiliations

1: Experimental Surgery and Regenerative Medicine, Department of Surgery, Ludwig-Maximilians-University (LMU), Munich, Germany.

Articles citing this

Transcription factor EGR1 directs tendon differentiation and promotes tendon repair. J Clin Invest (2013) 1.79

Retinoic acid receptor signaling preserves tendon stem cell characteristics and prevents spontaneous differentiation in vitrox. Stem Cell Res Ther (2016) 1.39

Common threads in cardiac fibrosis, infarct scar formation, and wound healing. Fibrogenesis Tissue Repair (2012) 1.12

Force and scleraxis synergistically promote the commitment of human ES cells derived MSCs to tenocytes. Sci Rep (2012) 1.11

Biologics for tendon repair. Adv Drug Deliv Rev (2014) 1.09

Uncovering the cellular and molecular changes in tendon stem/progenitor cells attributed to tendon aging and degeneration. Aging Cell (2013) 1.05

Transcription factor Mohawk controls tenogenic differentiation of bone marrow mesenchymal stem cells in vitro and in vivo. J Orthop Res (2014) 0.93

Advances in regenerative orthopedics. Mayo Clin Proc (2013) 0.89

Loss of tenomodulin results in reduced self-renewal and augmented senescence of tendon stem/progenitor cells. Stem Cells Dev (2014) 0.86

Probing the interaction forces of prostate cancer cells with collagen I and bone marrow derived stem cells on the single cell level. PLoS One (2013) 0.86

SRY induced TCF21 genome-wide targets and cascade of bHLH factors during Sertoli cell differentiation and male sex determination in rats. Biol Reprod (2012) 0.86

Retrovirus-mediated transduction of a cytosine deaminase gene preserves the stemness of mesenchymal stem cells. Exp Mol Med (2013) 0.85

Mechanical stimulation of human tendon stem/progenitor cells results in upregulation of matrix proteins, integrins and MMPs, and activation of p38 and ERK1/2 kinases. BMC Mol Biol (2015) 0.85

Gene therapy approaches to regenerating the musculoskeletal system. Nat Rev Rheumatol (2015) 0.84

Three-dimensional culture and transforming growth factor beta3 synergistically promote tenogenic differentiation of equine embryo-derived stem cells. Tissue Eng Part A (2014) 0.82

Regulation of Tenomodulin Expression Via Wnt/β-catenin Signaling in Equine Bone Marrow-derived Mesenchymal Stem Cells. J Equine Sci (2014) 0.82

A bioreactor system for in vitro tendon differentiation and tendon tissue engineering. J Orthop Res (2015) 0.82

Tenogenic modulating insider factor: Systematic assessment on the functions of tenomodulin gene. Gene (2016) 0.81

Scx-transduced tendon-derived stem cells (tdscs) promoted better tendon repair compared to mock-transduced cells in a rat patellar tendon window injury model. PLoS One (2014) 0.80

Growth factor delivery vehicles for tendon injuries: Mesenchymal stem cells and Platelet Rich Plasma. Muscles Ligaments Tendons J (2014) 0.79

Development of antisense oligonucleotide (ASO) technology against Tgf-β signaling to prevent scarring during flexor tendon repair. J Orthop Res (2015) 0.79

Markers for the identification of tendon-derived stem cells in vitro and tendon stem cells in situ - update and future development. Stem Cell Res Ther (2015) 0.79

Therapeutic Roles of Tendon Stem/Progenitor Cells in Tendinopathy. Stem Cells Int (2016) 0.79

Tendon development and musculoskeletal assembly: emerging roles for the extracellular matrix. Development (2015) 0.79

Tendon stem cells: experimental and clinical perspectives in tendon and tendon-bone junction repair. Muscles Ligaments Tendons J (2012) 0.78

Scleraxis is required for maturation of tissue domains for proper integration of the musculoskeletal system. Sci Rep (2017) 0.77

Mesenchymal stromal cells from bone marrow treated with bovine tendon extract acquire the phenotype of mature tenocytes. Rev Bras Ortop (2016) 0.77

Cellular and molecular maturation in fetal and adult ovine calcaneal tendons. J Anat (2014) 0.77

Induction of Tenogenic Differentiation Mediated by Extracellular Tendon Matrix and Short-Term Cyclic Stretching. Stem Cells Int (2016) 0.76

Using the zebrafish to understand tendon development and repair. Methods Cell Biol (2016) 0.76

Tenomodulin is Required for Tendon Endurance Running and Collagen I Fibril Adaptation to Mechanical Load. EBioMedicine (2017) 0.75

The Mkx homeoprotein promotes tenogenesis in stem cells and improves tendon repair. Ann Transl Med (2015) 0.75

Are bone marrow mesenchymal stem cells-induced tenogenic progenitor cells identical to tendon progenitor cells? Stem Cells Dev (2012) 0.75

Mechanical Control of Myotendinous Junction Formation and Tendon Differentiation during Development. Front Cell Dev Biol (2017) 0.75

Molecular characterization and function of tenomodulin, a marker of tendons and ligaments that integrate musculoskeletal components. Jpn Dent Sci Rev (2016) 0.75

Dental pulp stem cells express tendon markers under mechanical loading and are a potential cell source for tissue engineering of tendon-like tissue. Int J Oral Sci (2016) 0.75

Wnt/β-catenin signaling suppresses expressions of Scx, Mkx, and Tnmd in tendon-derived cells. PLoS One (2017) 0.75

Articles cited by this

Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19

Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell (2010) 15.58

PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell (1999) 9.74

TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science (2005) 5.56

Direct conversion of human fibroblasts to multilineage blood progenitors. Nature (2010) 5.35

Nuclear reprogramming to a pluripotent state by three approaches. Nature (2010) 5.26

Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell (2010) 5.13

Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med (2007) 4.80

Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev (2004) 4.43

In search of the in vivo identity of mesenchymal stem cells. Stem Cells (2008) 4.17

Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development (2001) 3.79

A somitic compartment of tendon progenitors. Cell (2003) 3.77

Regulation of tendon differentiation by scleraxis distinguishes force-transmitting tendons from muscle-anchoring tendons. Development (2007) 2.92

Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev (2004) 2.60

Scleraxis positively regulates the expression of tenomodulin, a differentiation marker of tenocytes. Dev Biol (2006) 2.31

Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Mol Cell Biol (2005) 2.10

Scleraxis: a basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development (1995) 1.99

Characterization of differential properties of rabbit tendon stem cells and tenocytes. BMC Musculoskelet Disord (2010) 1.80

Scleraxis and NFATc regulate the expression of the pro-alpha1(I) collagen gene in tendon fibroblasts. J Biol Chem (2007) 1.72

Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells. J Clin Invest (2006) 1.69

Tendon and ligament: development, repair and disease. Birth Defects Res C Embryo Today (2005) 1.68

Formation of odontoblast-like cells from cultured human dental pulp cells on dentin in vitro. J Endod (2006) 1.63

Structure-function relationships in tendons: a review. J Anat (2008) 1.56

Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone (2006) 1.50

Regulation of osteoblast differentiation by Runx2. Adv Exp Med Biol (2010) 1.47

Bone marrow-derived mesenchymal stem cells transduced with scleraxis improve rotator cuff healing in a rat model. Am J Sports Med (2011) 1.41

Mesenchymal stem cells differentiate into tenocytes by bone morphogenetic protein (BMP) 12 gene transfer. J Biosci Bioeng (2005) 1.38

Phenotypic drift in human tenocyte culture. Tissue Eng (2006) 1.36

Biomechanical properties and vascularity of an anterior cruciate ligament graft can be predicted by contrast-enhanced magnetic resonance imaging. A two-year study in sheep. Am J Sports Med (2001) 1.34

Introducing a single-cell-derived human mesenchymal stem cell line expressing hTERT after lentiviral gene transfer. J Cell Mol Med (2008) 1.31

A novel gene, tendin, is strongly expressed in tendons and ligaments and shows high homology with chondromodulin-I. Dev Dyn (2001) 1.26

Tissue engineering for bone defect healing: an update on a multi-component approach. Injury (2008) 1.22

Hypertrophy in mesenchymal stem cell chondrogenesis: effect of TGF-beta isoforms and chondrogenic conditioning. Cells Tissues Organs (2010) 1.21

Genetic analysis of interactions between the somitic muscle, cartilage and tendon cell lineages during mouse development. Development (2005) 1.20

Molecular cloning of tenomodulin, a novel chondromodulin-I related gene. Biochem Biophys Res Commun (2001) 1.18

Coordinated expression of scleraxis and Sox9 genes during embryonic development of tendons and cartilage. J Orthop Res (2002) 1.09

The basic helix-loop-helix transcription factor scleraxis regulates fibroblast collagen synthesis. J Mol Cell Cardiol (2009) 1.09

Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible. Stem Cells (2009) 1.07

BMP12 and BMP13 gene transfer induce ligamentogenic differentiation in mesenchymal progenitor and anterior cruciate ligament cells. Cytotherapy (2010) 1.06

Establishment of immortalized periodontal ligament progenitor cell line and its behavioural analysis on smooth and rough titanium surface. Eur Cell Mater (2010) 1.00

Overexpression of a single helix-loop-helix-type transcription factor, scleraxis, enhances aggrecan gene expression in osteoblastic osteosarcoma ROS17/2.8 cells. J Biol Chem (1997) 1.00

Quantitative polymerase chain reaction as a reliable method to determine functional lentiviral titer after ex vivo gene transfer in human mesenchymal stem cells. J Gene Med (2007) 0.99

Scleraxis and E47 cooperatively regulate the Sox9-dependent transcription. Int J Biochem Cell Biol (2009) 0.99

Tendon and ligament engineering: from cell biology to in vivo application. Regen Med (2006) 0.95

Lentiviral delivery of LMX1a enhances dopaminergic phenotype in differentiated human bone marrow mesenchymal stem cells. Stem Cells Dev (2009) 0.95

A combination of cis-acting elements is required to activate the pro-alpha 1(I) collagen promoter in tendon fibroblasts of transgenic mice. J Biol Chem (2002) 0.90

Transduction of Wnt11 promotes mesenchymal stem cell transdifferentiation into cardiac phenotypes. Stem Cells Dev (2011) 0.89

Effect of bone morphogenetic protein-12 gene transfer on mesenchymal progenitor cells. Clin Orthop Relat Res (1999) 0.88

Regulation of scleraxis function by interaction with the bHLH protein E47. Mol Cell Biol Res Commun (2000) 0.80

Articles by these authors

Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev (2003) 2.68

Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nat Med (2006) 2.03

Genetic variants in GPR126 are associated with adolescent idiopathic scoliosis. Nat Genet (2013) 1.90

Human mesenchymal stem cells in contact with their environment: surface characteristics and the integrin system. J Cell Mol Med (2007) 1.69

Hypoxia in static and dynamic 3D culture systems for tissue engineering of bone. Tissue Eng Part A (2008) 1.65

Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts. Anticancer Res (2005) 1.53

Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents. J Clin Invest (2010) 1.42

Researching into the cellular shape, volume and elasticity of mesenchymal stem cells, osteoblasts and osteosarcoma cells by atomic force microscopy. J Cell Mol Med (2008) 1.40

Introducing a single-cell-derived human mesenchymal stem cell line expressing hTERT after lentiviral gene transfer. J Cell Mol Med (2008) 1.31

Hydroxyapatite scaffolds for bone tissue engineering made by 3D printing. J Mater Sci Mater Med (2005) 1.30

Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study. J Craniomaxillofac Surg (2010) 1.28

Scx+/Sox9+ progenitors contribute to the establishment of the junction between cartilage and tendon/ligament. Development (2013) 1.26

Morphological and immunocytochemical characteristics indicate the yield of early progenitors and represent a quality control for human mesenchymal stem cell culturing. J Anat (2009) 1.24

Tissue engineering for bone defect healing: an update on a multi-component approach. Injury (2008) 1.22

Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I. J Cell Sci (2004) 1.16

Polychrome labeling of bone with seven different fluorochromes: enhancing fluorochrome discrimination by spectral image analysis. Bone (2005) 1.14

Human mesenchymal stem cells at the single-cell level: simultaneous seven-colour immunofluorescence. J Anat (2007) 1.10

Flexible intramedullary nailing for stabilization of displaced midshaft clavicle fractures: technique and results in 87 patients. Acta Orthop (2007) 1.08

IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesenchymal stem cells. J Mol Med (Berl) (2008) 1.06

Uncovering the cellular and molecular changes in tendon stem/progenitor cells attributed to tendon aging and degeneration. Aging Cell (2013) 1.05

Local tenomodulin absence, angiogenesis, and matrix metalloproteinase activation are associated with the rupture of the chordae tendineae cordis. Circulation (2008) 1.03

Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism. J Oral Maxillofac Surg (2010) 1.02

Hypoxic preconditioning of human mesenchymal stem cells overcomes hypoxia-induced inhibition of osteogenic differentiation. Tissue Eng Part A (2010) 1.01

Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells. J Gene Med (2005) 1.01

Quantitative polymerase chain reaction as a reliable method to determine functional lentiviral titer after ex vivo gene transfer in human mesenchymal stem cells. J Gene Med (2007) 0.99

Effect of collagen I and fibronectin on the adhesion, elasticity and cytoskeletal organization of prostate cancer cells. Biochem Biophys Res Commun (2010) 0.99

Scleraxis and E47 cooperatively regulate the Sox9-dependent transcription. Int J Biochem Cell Biol (2009) 0.99

Chondromodulin I is a bone remodeling factor. Mol Cell Biol (2003) 0.97

Increased stemness and migration of human mesenchymal stem cells in hypoxia is associated with altered integrin expression. Biochem Biophys Res Commun (2012) 0.97

Dual effects of the membrane-anchored MMP regulator RECK on chondrogenic differentiation of ATDC5 cells. J Cell Sci (2007) 0.96

First inducible transgene expression in porcine large animal models. FASEB J (2011) 0.96

Validation of a femoral critical size defect model for orthotopic evaluation of bone healing: a biomechanical, veterinary and trauma surgical perspective. Tissue Eng Part C Methods (2008) 0.96

Solid-supported lipid bilayers to drive stem cell fate and tissue architecture using periosteum derived progenitor cells. Biomaterials (2012) 0.96

Impact of indium-111 oxine labelling on viability of human mesenchymal stem cells in vitro, and 3D cell-tracking using SPECT/CT in vivo. Mol Imaging Biol (2011) 0.95

Expression and localization of tenomodulin, a transmembrane type chondromodulin-I-related angiogenesis inhibitor, in mouse eyes. Invest Ophthalmol Vis Sci (2003) 0.94

Direct conversion of tenocytes into chondrocytes by Sox9. Exp Cell Res (2012) 0.93

Differentiation of individual human mesenchymal stem cells probed by FTIR microscopic imaging. Analyst (2007) 0.92

Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle? J Oral Maxillofac Surg (2010) 0.91

New advances in fluorochrome sequential labelling of teeth using seven different fluorochromes and spectral image analysis. J Anat (2007) 0.91

Immobilization of bioactive fibroblast growth factor-2 into cubic proteinous microcrystals (Bombyx mori cypovirus polyhedra) that are insoluble in a physiological cellular environment. J Biol Chem (2007) 0.89

Cartilaginous features in matrix-producing carcinoma of the breast: four cases report with histochemical and immunohistochemical analysis of matrix molecules. Mod Pathol (2008) 0.89

Arthritic periosteal tissue from joint replacement surgery: a novel, autologous source of stem cells. Stem Cells Transl Med (2014) 0.88

Characterisation of a new bioadhesive system based on polysaccharides with the potential to be used as bone glue. J Mater Sci Mater Med (2009) 0.88

Effects of different media on proliferation and differentiation capacity of canine, equine and porcine adipose derived stem cells. Res Vet Sci (2011) 0.87

Mesenchymal stem cells from osteoporotic patients feature impaired signal transduction but sustained osteoinduction in response to BMP-2 stimulation. Biochem Biophys Res Commun (2013) 0.87

Immunohistochemical evaluation of cartilage-derived morphogenic protein-1 and -2 in normal human salivary glands and pleomorphic adenomas. Virchows Arch (2003) 0.87

Influence of in vitro cultivation on the integration of cell-matrix constructs after subcutaneous implantation. Tissue Eng (2007) 0.86

Loss of tenomodulin results in reduced self-renewal and augmented senescence of tendon stem/progenitor cells. Stem Cells Dev (2014) 0.86

Impairment of VEGF-A-stimulated lamellipodial extensions and motility of vascular endothelial cells by chondromodulin-I, a cartilage-derived angiogenesis inhibitor. Exp Cell Res (2009) 0.86

Probing the interaction forces of prostate cancer cells with collagen I and bone marrow derived stem cells on the single cell level. PLoS One (2013) 0.86

Angiogenesis inhibitors localized in hypovascular mesenchymal tissues: chondromodulin-I and tenomodulin. Connect Tissue Res (2005) 0.85

Bupivacaine, ropivacaine, and morphine: comparison of toxicity on human hamstring-derived stem/progenitor cells. Knee Surg Sports Traumatol Arthrosc (2011) 0.85

Tenomodulin expression in the periodontal ligament enhances cellular adhesion. PLoS One (2013) 0.85

Reprogramming of active and repressive histone modifications following nuclear transfer with rabbit mesenchymal stem cells and adult fibroblasts. Cloning Stem Cells (2009) 0.84

Cyanoacrylate glue for intra-abdominal mesh fixation of polypropylene-polyvinylidene fluoride meshes in a rabbit model. J Surg Res (2009) 0.84

Generation and characterization of ScxCre transgenic mice. Genesis (2013) 0.83

Cartilage-specific matrix protein, chondromodulin-I (ChM-I), is a strong angio-inhibitor in endochondral ossification of human neonatal vertebral tissues in vivo: relationship with angiogenic factors in the cartilage. Acta Histochem (2002) 0.83

Differential actions of VEGF-A isoforms on perichondrial angiogenesis during endochondral bone formation. Dev Biol (2009) 0.83

Long-term detection of fluorescently labeled human mesenchymal stem cell in vitro and in vivo by semi-automated microscopy. Tissue Eng Part C Methods (2011) 0.83

Transcriptome analysis of early chondrogenesis in ATDC5 cells induced by bone morphogenetic protein 4. Genomics (2004) 0.82

Pax1 acts as a negative regulator of chondrocyte maturation. Exp Cell Res (2013) 0.82

A functional role of the glycosylated N-terminal domain of chondromodulin-I. J Bone Miner Metab (2010) 0.82

Collagen type I and decorin expression in tenocytes depend on the cell isolation method. BMC Musculoskelet Disord (2012) 0.81

Quantification of fluorescence intensity of labeled human mesenchymal stem cells and cell counting of unlabeled cells in phase-contrast imaging: an open-source-based algorithm. Tissue Eng Part C Methods (2010) 0.80

Suppression of T cell responses by chondromodulin I, a cartilage-derived angiogenesis inhibitory factor: therapeutic potential in rheumatoid arthritis. Arthritis Rheum (2004) 0.80

Characterization of adipose-derived equine and canine mesenchymal stem cells after incubation in agarose-hydrogel. Vet Res Commun (2011) 0.80

MiR-134-mediated β1 integrin expression and function in mesenchymal stem cells. Biochim Biophys Acta (2013) 0.80

Interactions of human endothelial and multipotent mesenchymal stem cells in cocultures. Open Biomed Eng J (2010) 0.80

Overcoming hypoxia in 3D culture systems for tissue engineering of bone in vitro using an automated, oxygen-triggered feedback loop. J Mater Sci Mater Med (2012) 0.80

Synthetic disulfide-bridged cyclic peptides mimic the anti-angiogenic actions of chondromodulin-I. Cancer Sci (2012) 0.79

A small scale cell culture system to analyze mechanobiology using reporter gene constructs and polyurethane dishes. Eur Cell Mater (2010) 0.79

Membrane-based cultures generate scaffold-free neocartilage in vitro: influence of growth factors. Tissue Eng Part A (2010) 0.79

Expression and localization of cartilage-specific matrix protein chondromodulin-I mRNA in salivary pleomorphic adenomas. Virchows Arch (2004) 0.78